Serenace en es it fr

Serenace Brand names, Serenace Analogs

Serenace Brand Names Mixture

  • No information avaliable

Serenace Chemical_Formula


Serenace RX_link

Serenace fda sheet

Serenace FDA

Serenace msds (material safety sheet)

Serenace MSDS

Serenace Synthesis Reference

P. A. J. Janssen, Belg. pat. 577,977 (1959), C.A. 54, 4630c (1960); idem, Brit. pat. 895,309 corresp to U.S. pat. 3,438,991 (1962, 1969 to Janssen).

Serenace Molecular Weight

375.864 g/mol

Serenace Melting Point

151.5 oC

Serenace H2O Solubility

14 mg/L

Serenace State


Serenace LogP


Serenace Dosage Forms

Injection; Oral solution; Tablet

Serenace Indication

For the treatment of schizophrenic patients who require prolonged parenteral antipsychotic therapy also used in Tourette's syndrome and Severe hyperactivity.

Serenace Pharmacology

Haloperidol is a psychotropic agent indicated for the treatment of schizophrenia. It also exerts sedative and antiemetic activity. Haloperidol has actions at all levels of the central nervous system-primarily at subcortical levels-as well as on multiple organ systems. Haloperidol has strong antiadrenergic and weaker peripheral anticholinergic activity; ganglionic blocking action is relatively slight. It also possesses slight antihistaminic and antiserotonin activity.

Serenace Absorption


Serenace side effects and Toxicity

LD50=165 mg/kg (rats, oral)

Serenace Patient Information


Serenace Organisms Affected

Humans and other mammals